Panacea Biotec Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Panacea Biotec Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 2.48 billion Japanese Yen [US$22.12 million]
of which 63%
was Health Inspection Equipment),
China Regenerative Medicine International Ltd
of Hong Kong
(356.99 million Hong Kong Dollars [US$45.72 million]
of which 51%
was Medical Products and Equipment), and
Pharma Foods International Co.Ltd
based in Japan
(4.72 billion Japanese Yen [US$42.08 million]
Panacea Biotec Ltd reported sales of 5.39 billion Indian Rupees (US$82.84 million)
March of 2017.
decrease of 17.5%
versus 2016, when the company's sales were 6.53 billion Indian Rupees.
Contributing to the drop in overall sales was the 35.5% decline
in Vaccine, from 2.53 billion Indian Rupees to 1.63 billion Indian Rupees.
There were also decreases in sales in
Formulation (down 3.8% to 3.72 billion Indian Rupees)
Research and Development (down 30.3% to 91.20 million Indian Rupees)